A detailed history of Lord, Abbett & Co. LLC transactions in Artivion, Inc. stock. As of the latest transaction made, Lord, Abbett & Co. LLC holds 374,834 shares of AORT stock, worth $16.2 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
374,834
Previous 401,904 6.74%
Holding current value
$16.2 Million
Previous $9.88 Million 18.0%
% of portfolio
0.04%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

SELL
$22.19 - $31.19 $600,683 - $844,313
-27,070 Reduced 6.74%
374,834 $11.7 Million
Q1 2025

May 13, 2025

BUY
$23.19 - $31.7 $2.21 Million - $3.02 Million
95,202 Added 31.04%
401,904 $9.88 Million
Q4 2024

Feb 14, 2025

BUY
$25.41 - $30.11 $2.26 Million - $2.68 Million
88,902 Added 40.82%
306,702 $8.77 Million
Q3 2024

Nov 14, 2024

BUY
$24.33 - $28.46 $5.3 Million - $6.2 Million
217,800 New
217,800 $5.8 Million

Others Institutions Holding AORT

About ARTIVION, INC.


  • Ticker AORT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 40,316,100
  • Market Cap $1.74B
  • Description
  • Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...
More about AORT
Track This Portfolio

Track Lord, Abbett & Co. LLC Portfolio

Follow Lord, Abbett & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.